Compound: KIN001-042

Drug Target: GSK3B

Drug Target pathway: WNT signaling

DatasetDatasets
GDSC1: Screened in 96 or 384-well plates with Cyto60 or Resazurin endpoint
GDSC2 (recommended where available): 1536-well plates with CellTiterGlo endpoint
See documentation for more information and screening differences


Tissue specific analysis

KIN001-042 IC50 values for cnaPANCAN103

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.